Digital The digital future: Sanofi’s Marc Schwartz In this series we speak to pharma leaders to get their views on the biggest trends in digital pharma.
News FDA starts swift review of GSK antibiotic for gonorrhoea An oral alternative to injectable treatment for uncomplicated gonorrhoea could be on the way in the US, as FDA starts review of GSK's gepotidacin.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face